German manufacturer of Kwai garlic supplement plans to launch two new products in U.S. health food and mass market outlets in October - Cynara-SL artichoke extract and Sedonium valerian extract, the company said at the recent National Nutritional Foods Association Marketplace trade show in Las Vegas. Cynara-SL, an extract of Globe artichoke (Cynara scolymus) leaves, has been "clinically proven to help maintain a healthy liver and digestive system," labeling states. The product provides "nutritional support when you eat and drink too much," the package says. Sedonium, "clinically proven to help promote restful sleep," contains 300 mg valerian root extract. "Take two at bed time. Awake refreshed and alert," labeling claims. Consumer and trade print ads are slated for the fourth quarter. Both products, available in 30-tablet blister packs, carry the FDA disclaimer required under the Dietary Supplement Health & Education Act. Lichtwer Pharma is moving its U.S. corporate offices from Pittsburgh to Eatontown, N.J
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
Ultragenyx said talks with the FDA about a path forward after receiving a CRL for UX111 have been productive despite the recent upheaval at the agency.
Many agency stakeholders believe Vinay Prasad may be forced to change his regulatory approach at least somewhat after receiving a second chance to lead the US FDA's biologics center.
The International Council for Harmonisation has developed a holistic approach for the assessment and control of leachable impurities, supporting drug product development, registration and ongoing quality management throughout the product lifecycle.
